ESQ
Esquire Financial Holdings, Inc.
ESQ trails on the overall score without a compensating advantage in the available component scores.
JPM
JPMorgan Chase & Co.
JPM has the edge over ESQ overall, supported by stronger valuation and stronger fundamentals.
ESQ Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| N/A | |
| N/A |
ESQ's revenue and profitability are currently strong. Free cash flow and net leverage aren't meaningful measures for financial services companies like ESQ.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
ESQ PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 10x | $60.68 | -54% |
| Fair | 14x | $83.73 | -36% |
| Forward | 15x | $132 | — |
| Expensive | 18x | $108 | -18% |
| Current | 22x | $132 | — |
Historical ranges are pointers, not guarantees.
ESQ's PE is in its expensive range at 22x. If earnings grow as analysts expect, today's price would be 15x next year's earnings, in its fair range.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM has the edge over ESQ in the historical PE scenario, which offers more potential upside but is not a forecast.
ESQ Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect strong earnings and revenue growth for ESQ, but weaker profitability.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
ESQ Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $8.80 | +47% |
| Q3 2026 | $6.00 | +5.6% |
| Q2 2026 | $6.05 | +12% |
| Q1 2026 | $5.94 | +13% |
| Q4 2025 | $5.87 | +14% |
| Q3 2025 | $5.68 | +15% |
| Q2 2025 | $5.40 | +13% |
| Q1 2025 | $5.27 | +14% |
| Q4 2024 | $5.14 | +4.7% |
ESQ's earnings per share have climbed steadily: $6.00 over the past year, up 5.6% from the year before, and higher year over year for 23 quarters in a row.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the edge over ESQ on earnings, with stronger typical year-over-year growth.
ESQ Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $61.4M | +63% |
| Q2 2026 | $42.1M | +18% |
| Q1 2026 | $40.5M | +20% |
| Q4 2025 | $39.4M | +19% |
| Q3 2025 | $37.6M | +18% |
| Q2 2025 | $35.8M | +17% |
| Q1 2025 | $33.8M | +15% |
| Q4 2024 | $33.1M | +14% |
ESQ has the edge over JPM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 38% | -8 points |
| Q2 2026 | 43% | +0.5 points |
| Q1 2026 | 42% | -3.7 points |
| Q4 2025 | 44% | -3.2 points |
| Q3 2025 | 46% | -2.3 points |
| Q2 2025 | 43% | -4.4 points |
| Q1 2025 | 46% | -0.8 points |
| Q4 2024 | 47% | +0.6 points |
ESQ's operating margin was 38% last quarter, down 8 points from the same quarter a year ago.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over ESQ on profitability, with a higher operating margin.
ESQ Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $13M | -20% |
| Q2 2026 | $14.4M | +54% |
| Q1 2026 | $19.3M | +32% |
| Q4 2025 | $16.5M | +42% |
| Q3 2025 | $16.2M | +55% |
| Q2 2025 | $9.3M | +36% |
| Q1 2025 | $14.7M | +17% |
| Q4 2024 | $11.6M | -29% |
ESQ has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
ESQ Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +28% | +2.4M shares |
| 1 year | +28% | +2.5M shares |
| 3 years | +33% | +2.8M shares |
| 5 years | +40% | +3.2M shares |
| Available history | +43% | +3.4M shares |
ESQ has 11M diluted shares, up 28% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2023 | — |
| Q3 2023 | — |
| Q1 2023 | $268,000 |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | $82,000 |
| Q1 2020 | $485,000 |
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over ESQ on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
ESQ Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -5.8x | Net Cash |
| Q2 2026 | -3.4x | Net Cash |
| Q1 2026 | -3.2x | Net Cash |
| Q4 2025 | -3.5x | Net Cash |
| Q3 2025 | -3.7x | Net Cash |
| Q2 2025 | -2.6x | Net Cash |
| Q1 2025 | -2.8x | Net Cash |
| Q4 2024 | -2.1x | Net Cash |
ESQ has the edge over JPM on leverage, with a lower net debt burden relative to earnings.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
ESQ Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 63.7 | Neutral |
| Stochastic | 75.2 | Neutral |
ESQ's weekly RSI is 64 (neutral) and its Stochastic is 75 (neutral).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
ESQ PE vs Financial Services Sector
| Metric | ESQ | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 13x | 69% above |
| PE % | 100 | 63 | 37 pts above |
ESQ is trading at 22x earnings, a 69% premium to the Financial Services sector's median of 13x.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM has the edge over ESQ on valuation relative to its sector.
ESQ Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $123.6 | 6.5% above |
| 20 week MA | $122.4 | 7.6% above |
| 50 week MA | $113.9 | 16% above |
| 100 week MA | $101.8 | 29% above |
| 200 week MA | $76.0 | 73% above |
ESQ has the edge over JPM on trend strength, trading above more of its moving averages.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM's trend is mixed: it's above four of its five weekly moving averages, and 45% above its 200-week average.
ESQ Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $26.7 | $19.3 | -28% |
| 2021 | $19.3 | $31.3 | +63% |
| 2022 | $31.3 | $42.8 | +37% |
| 2023 | $42.8 | $50.0 | +17% |
| 2024 | $50.0 | $78.8 | +58% |
| 2025 | $78.8 | $105.0 | +33% |
| 2026 YTD | $105.0 | $131.7 | +25% |
ESQ has the edge over JPM on returns for 2026, with the stronger performance.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.